Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
FDA Warns Hologic Over BioZorb Manufacturing Violations
Via Benzinga
Exposures Product Safety
Tickers HOLX
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
Via Benzinga
Exposures Product Safety
Tickers AMGN
FDA Approves AstraZeneca's Calquence Combo Therapy For Untreated Mantle Cell Lymphoma
Via Benzinga
Exposures Product Safety
Tickers AZN
APLT DEADLINE ALERT: Applied Therapeutics Investors Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT DEADLINE ALERT: Applied Therapeutics Investors Are Encouraged to Contact Kaplan Fox Before Lead Plaintiff Deadline on February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
Via TheNewswire.com
Exposures Product Safety
Tickers GOVX
ZYN Nicotine Pouches Receive FDA Marketing Approval
Via Benzinga
Exposures Product Safety
Tickers PM
FDA Approves Expanded Use Of Eli Lilly's Ulcerative Colitis Drug For Crohn's Disease
Via Benzinga
Exposures Product Safety
Tickers LLY
Philip Morris Stock Rises On FDA Approval For Zyn Nicotine Pouches: Retail’s Upbeat
Via Stocktwits
Exposures Product Safety
Tickers PM VOO VTI XLP
ImmunityBio Stock Trading Higher On Updates From Bladder Cancer Trials: Details
Via Benzinga
Exposures Product Safety
Tickers IBRX
FDA Unveils Grounds For Rejecting Vanda Pharmaceuticals Stomach Paralysis Candidate
Via Benzinga
Exposures Product Safety
Tickers VNDA
APPLIED THERAPEUTICS INVESTOR ALERT: Kaplan Fox Alerts Investors of a Class Action Deadline on February 18, 2024
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APPLIED THERAPEUTICS INVESTOR ALERT: Kaplan Fox Alerts Investors of a Class Action Deadline on February 18, 2024
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Atara Stock Plunges To 3-Month Low After FDA Blocks Blood Cancer Drug: Retail's Buying The Dip
Via Stocktwits
Exposures Product Safety
Tickers ATRA VTI VXF
Outlook Therapeutics Vision Loss Drug At Par With Novartis Drug
Via Benzinga
Exposures Product Safety
Tickers AMD NVS OTLK RHHBY
FDA Bans Red Dye No. 3 Yet To Dismiss AATCLC Lawsuit To Have Menthol In Cigarettes Banned
Via PRLog
Topics Lawsuit
Exposures Financial Legal Product Safety
Vertex's Pain Drug: Big Pharma's Next Major Success?
Via MarketBeat
Exposures Product Safety
Tickers CRSP VRTX
FDA Bans Red Dye No. 3 Effective January 2027, Cites Cancer Risks: Food Stocks To Watch
Via Benzinga
Exposures Product Safety
Tickers ABT COST GIS TAK
APLT SHAREHOLDER ALERT: Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
APLT SHAREHOLDER ALERT: Deadline to Lead in Securities Fraud Lawsuit Against Applied Therapeutics, Inc. (APLT) is February 18, 2025 - Contact Kaplan Fox
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Celebrating 20 Years: Quality Home Inspections Reflect on Success and Future
Via Press Release Distribution Service
Topics Product Recall
Exposures Legal Product Safety
GeoVax Announces Major Gedeptin Milestone With Plans of Phase 2 Trial
Via NewMediaWire
Exposures Product Safety
Tickers GOVX
Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials
Via Benzinga
Exposures Product Safety
Tickers VRTX
FDA Proposes Front-Of-Package Label To Improve Nutrition Transparency
Via Benzinga
Exposures Product Safety
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
Via Benzinga
Exposures Product Safety
Tickers BIIB
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kaplan Fox Alerts Applied Therapeutics Investors to a Securities Class Action Lawsuit - Deadline is February 18, 2025
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Is a Ford Stock Turnaround on the Horizon?
Via MarketBeat
Topics Economy Electric Vehicles Government
Exposures Electric Vehicles Legal Political
Tickers F GM RIVN TSLA
22nd Century Group Stock Rises On Proposed FDA Mandate On Nicotine Content: Retail's Extremely Bullish
Via Stocktwits
Exposures Product Safety
Tickers VXF XXII
APLT DEADLINE ALERT: Kaplan Fox Reminds Investors of a Class Action Lawsuit Against Applied Therapeutics, Inc. (APLT) and Lead Plaintiff Deadline on February 18, 2025
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.